Insulet Corp (PODD)
240.80
+3.23
(+1.36%)
USD |
NASDAQ |
Nov 05, 14:45
Insulet Cash from Investing (Quarterly): -24.90M for June 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -24.90M |
| March 31, 2024 | -24.00M |
| December 31, 2023 | -31.60M |
| September 30, 2023 | -22.60M |
| June 30, 2023 | -23.10M |
| March 31, 2023 | -42.10M |
| December 31, 2022 | -88.40M |
| September 30, 2022 | -33.90M |
| June 30, 2022 | -21.90M |
| March 31, 2022 | -46.90M |
| December 31, 2021 | -36.40M |
| September 30, 2021 | -12.20M |
| June 30, 2021 | -11.40M |
| March 31, 2021 | -22.70M |
| December 31, 2020 | -69.30M |
| September 30, 2020 | 2.70M |
| June 30, 2020 | 67.20M |
| March 31, 2020 | 13.40M |
| December 31, 2019 | -54.00M |
| September 30, 2019 | 12.20M |
| June 30, 2019 | -39.40M |
| March 31, 2019 | 7.60M |
| December 31, 2018 | -40.78M |
| September 30, 2018 | -26.62M |
| June 30, 2018 | -61.12M |
| Date | Value |
|---|---|
| March 31, 2018 | -55.99M |
| December 31, 2017 | -149.32M |
| September 30, 2017 | 2.781M |
| June 30, 2017 | -21.98M |
| March 31, 2017 | -42.29M |
| December 31, 2016 | -97.18M |
| September 30, 2016 | -45.04M |
| June 30, 2016 | -37.24M |
| March 31, 2016 | 1.454M |
| December 31, 2015 | -3.482M |
| September 30, 2015 | -7.24M |
| June 30, 2015 | -0.255M |
| March 31, 2015 | -4.346M |
| December 31, 2014 | -2.633M |
| September 30, 2014 | -3.108M |
| June 30, 2014 | -3.588M |
| March 31, 2014 | -2.157M |
| December 31, 2013 | -2.79M |
| September 30, 2013 | -1.822M |
| June 30, 2013 | -1.626M |
| March 31, 2013 | -1.069M |
| December 31, 2012 | -2.055M |
| September 30, 2012 | -4.687M |
| June 30, 2012 | -2.55M |
| March 31, 2012 | -1.699M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-88.40M
Minimum
Dec 2022
67.20M
Maximum
Jun 2020
-25.37M
Average
-24.00M
Median
Mar 2024
Cash from Investing (Quarterly) Benchmarks
| Baxter International Inc | -91.00M |
| Boston Scientific Corp | -1.427B |
| Abbott Laboratories | -594.00M |
| Globus Medical Inc | -10.38M |
| Bioventus Inc | -0.077M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 96.50M |
| Cash from Financing (Quarterly) | -0.90M |
| Free Cash Flow | 182.40M |
| Free Cash Flow Per Share (Quarterly) | 0.9702 |
| Free Cash Flow to Equity (Quarterly) | 75.30M |
| Free Cash Flow to Firm (Quarterly) | 77.87M |
| Free Cash Flow Yield | 0.99% |